HDinHD: Open Source Science for the HD Research Community
The goal of HDinHD is to foster and support a collaborative community united in its drive to accelerate the development of therapeutics that will delay the onset and/or ameliorate the effects of Huntington’s disease. HDinHD seeks to achieve this through:
- Sharing HD-related primary scientific data
- Sharing analyses and computational models built from HD-related scientific data
- Providing browsing and data interrogation tools over both primary and analyzed data that facilitate data exploration and hypothesis generation
- Building a forum for HD researchers to highlight their data, tools, know-how and insight to the community
The HDinHD website is currently a joint development effort by CHDI and UCLA, through the laboratory of Dr. Giovanni Coppola. As you will see when you Register for access, HDinHD highlights data and tools provided by the broader community. If you are interested in Contributing Data to HDinHD, suggest links to other HD-related scientific data or websites, or would otherwise like to provide Feedback to us, we encourage you to do so. HDinHD is for the community; please help us tailor and grow HDinHD in a direction that can make a difference to your research, and ultimately, to improve the lives of HD families.
Want to learn more about HDinHD?
Watch a detailed video overview of HDinHD presented at the 16th Annual HD Therapeutics Conference (April 2021). The video outlines data resources and tools within HDinHD and provides a detailed demonstration of the new HD Explorer tool. |
Read the following publication introducing HDinHD: HDinHD: A Rich Data Portal for Huntington’s Disease Research, J Huntingtons Dis., 10, 405-412
Latest news and publications from around the HD Ecosystem
HDBuzz
- A New Key to HD? How TDP43 Might Spoil The Show
- Steadying genetic stumble could help slow Huntington's disease
- Community voices power change through research surveys
- Huntington’s Disease Clinical Expert Prof. Ed Wild Shares Hopeful View For 2025
- New Insights Into Why Huntington’s Disease Has Delayed Onset
Literature
- Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology
- MTH1 in the disorders of the central nervous system: scope beyond brain tumors and challenges
- Evaluating Determinants of Length of Stay in Burn Care: Is One Day per 1% Total Burn Surface Area Still Accurate?
- Treating incurable non-communicable diseases by targeting iron metabolism and ferroptosis
- The roles of intrinsically disordered proteins in neurodegeneration
News
- LoQus23 Therapeutics appoints Cyrus Mozayeni MD to Chair of the Board of Directors
- 2024's top 10 clinical trial flops - Fierce Biotech
- Artificial Intelligence in Videofluoroscopy Swallow Study Analysis: A Comprehensive Review
- Neurogenesis altered by disease and stimulation | Nature Reviews Neurology
- MMJ Marijuana Waiting FDA Approved Huntington's Clinical Trials As RFK Jr.'s Push to ...